Overall rank by patents
#1,813
Across all tracked assignees
USPTO PatentsView assignee record - 224 granted patents across 48 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C08F (MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS).
The verdict
Basell holds 224 US patents across 48 technology areas, rank #1,813 of 50,000 tracked assignees.
Basell Poliolefine Italia S.r.l. has been granted 224 US utility patents between 2015 and 2025, placing Basell Poliolefine Italia S.r.l. at rank #1,813 across all assignees tracked by PlainPatent. This portfolio spans 48 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.5 claims per patent with primary concentration in C08F (MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS). As a Foreign Corporation, Basell Poliolefine Italia S.r.l. is one of the more focused assignees in the PatentsView dataset. By volume, Basell sits between Philips Image Guided Therapy Corporation (225 patents, rank #1,809) and University Health Network (224 patents, rank #1,817) - the closest US assignees by grant volume. The composite Innovation Score of 54.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 97 grants, compared with 127 in the 2015–2019 window, a -24% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Basell Poliolefine Italia S.r.l.'s 10.5 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 48 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Basell Poliolefine Italia S.r.l. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
PHILIPS IMAGE GUIDED THERAPY CORPORATION
225 patents
THALES DIS FRANCE SAS
225 patents
3D SYSTEMS, INC.
224 patents
AFL Telecommunications LLC
224 patents
HUIZHOU KIMREE TECHNOLOGY CO., LTD. SHENZHEN BRANCH
224 patents
JNC PETROCHEMICAL CORPORATION
224 patents
LEICA GEOSYSTEMS AG
224 patents
UNIVERSITY HEALTH NETWORK
224 patents
Basell Poliolefine Italia S.r.l.
224 patents
What this shows Basell holds 224 patents at rank #1,813, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,813 in granted patent volume.
Other assignees with the most granted patents in Basell's primary technology class.
Basell's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
54 Top 8% higher than 92% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 27 | 12.1% |
| 2016 | 24 | 10.7% |
| 2017 | 27 | 12.1% |
| 2018 | 27 | 12.1% |
| 2019 | 22 | 9.8% |
| 2020 | 24 | 10.7% |
| 2021 | 16 | 7.1% |
| 2022 | 17 | 7.6% |
| 2023 | 10 | 4.5% |
| 2024 | 18 | 8.0% |
| 2025 | 12 | 5.4% |
Top 15 of 48 technology areas
Overall rank by patents
#1,813
Across all tracked assignees
54.4 out of 100
How to use this portfolio
Basell's 224 grants land it in the top 8% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.